BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14960965)

  • 1. Hepatocyte growth factor in polymorphonuclear leukocytes is increased in patients with systemic inflammatory response syndrome.
    Matsushima A; Ogura H; Koh T; Fujita K; Yoshiya K; Sumi Y; Hosotsubo H; Kuwagata Y; Tanaka H; Shimazu T; Sugimoto H
    J Trauma; 2004 Feb; 56(2):259-64. PubMed ID: 14960965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of intranuclear NF-kappa B in primed polymorphonuclear leukocytes in systemic inflammatory response syndrome patients.
    Nakamori Y; Koh T; Ogura H; Tanaka H; Fujimi S; Kasai K; Hosotubo H; Shimazu T; Sugimoto H
    J Trauma; 2003 Feb; 54(2):253-60. PubMed ID: 12579048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical cytoskeleton and microparticle formation changes in monocytes and polymorphonuclear leukocytes in severe systemic inflammatory response syndrome patients.
    Itakura Sumi Y; Ogura H; Tanaka H; Koh T; Fujita K; Fujimi S; Nakamori Y; Shimazu T; Sugimoto H
    J Trauma; 2003 Dec; 55(6):1125-32. PubMed ID: 14676659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated human neutrophils release hepatocyte growth factor/scatter factor.
    McCourt M; Wang JH; Sookhai S; Redmond HP
    Eur J Surg Oncol; 2001 Jun; 27(4):396-403. PubMed ID: 11417987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of aquaporin 9 in activated polymorphonuclear leukocytes in patients with systemic inflammatory response syndrome.
    Matsushima A; Ogura H; Koh T; Shimazu T; Sugimoto H
    Shock; 2014 Oct; 42(4):322-6. PubMed ID: 24978896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome.
    Torre D; Tambini R; Aristodemo S; Gavazzeni G; Goglio A; Cantamessa C; Pugliese A; Biondi G
    Mediators Inflamm; 2000; 9(3-4):193-5. PubMed ID: 11132778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers.
    Nayeri F; Olsson H; Peterson C; Sundqvist T
    J Dermatol Sci; 2005 Feb; 37(2):75-85. PubMed ID: 15659325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The balance between expression of intranuclear NF-kappaB and glucocorticoid receptor in polymorphonuclear leukocytes in SIRS patients.
    Nakamori Y; Ogura H; Koh T; Fujita K; Tanaka H; Sumi Y; Hosotsubo H; Yoshiya K; Irisawa T; Kuwagata Y; Shimazu T; Sugimoto H
    J Trauma; 2005 Aug; 59(2):308-14; discussion 314-5. PubMed ID: 16294069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation.
    Chung S; Kim JE; Kim JY; Lee DS; Han KS; Kim HK
    Thromb Res; 2010 Jun; 125(6):e285-93. PubMed ID: 20185166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
    de Jong KP; Hoedemakers RM; Fidler V; Bijzet J; Limburg PC; Peeters PM; de Vries EG; Slooff MJ
    Scand J Gastroenterol; 2004 Nov; 39(11):1141-8. PubMed ID: 15545174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepatocyte growth factor levels are increased in patients with congestive heart failure.
    Ueno S; Ikeda U; Hojo Y; Arakawa H; Nonaka M; Yamamoto K; Shimada K
    J Card Fail; 2001 Dec; 7(4):329-34. PubMed ID: 11782856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
    Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
    Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation.
    Miyaoka K; Iwase M; Suzuki R; Kondo G; Watanabe H; Ito D; Nagumo M
    J Surg Res; 2005 May; 125(2):144-50. PubMed ID: 15854666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased growth factor expression after hepatic and pancreatic resection.
    Justinger C; Schlüter C; Oliviera-Frick V; Kopp B; Rubie C; Schilling MK
    Oncol Rep; 2008 Dec; 20(6):1527-31. PubMed ID: 19020737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between IL-6 levels and the systemic inflammatory response score: can an IL-6 cutoff predict a SIRS state?
    Giannoudis PV; Harwood PJ; Loughenbury P; Van Griensven M; Krettek C; Pape HC
    J Trauma; 2008 Sep; 65(3):646-52. PubMed ID: 18784579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.
    Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole blood leukocyte mitogen activated protein kinases activation differentiates intensive care unit patients with systemic inflammatory response syndrome and sepsis.
    West MA; Koons A; Crandall M; Skinner R; Worley M; Shapiro MB
    J Trauma; 2007 Apr; 62(4):805-11. PubMed ID: 17426533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic changes in serum levels of cytokines in patients with systemic inflammatory response syndrome].
    Mei X; Li CS; Wang S
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Feb; 18(2):85-8. PubMed ID: 16512636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM; Liu YW; Eng HL; Chou FF
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of hepatocyte growth factor in patients with gastrointestinal and pancreatic diseases with special reference to inflammatory bowel disease.
    Matsuno M; Shiota G; Umeki K; Kawasaki H; Kojo H; Miura K
    Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):25-37. PubMed ID: 9507565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.